Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 16, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inhibrx Biosciences, Inc.
| 40K |
$15.73 | $629,116.96 | +6.01% | 705.55K |
Sep 12 - Sep 16
| |||||||
Inhibrx Biosciences, Inc.
| 44K |
$15.25 | $671,150.00 | +7.08% | 665.55K |
Sep 6 - Sep 10
| |||||||
Inhibrx Biosciences, Inc.
| 40K |
$14.92 | $596,762.80 | +32.00% | 165K |
Aug 29 - Sep 3
| |||||||
Inhibrx Biosciences, Inc.
| 40K |
$12.96 | $518,282.20 | +269.09% | 54.87K |
Aug 20 - Aug 21
| |||||||
Inhibrx, Inc.
| -3.05M |
$30.00 | -$91,369,620.00 | -100.00% |
0
|
May 30
| |||||||
Inhibrx Biosciences, Inc.
| 761.41K |
—
|
—
|
∞
| 761.41K |
May 29 - May 30
| |||||||
Inhibrx Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Inhibrx, Inc.
| -60.00 |
$25.02 | -$1,501.25 | -0.00% | 2.49M |
Feb 28
|
Scheduled
| ||||||
Inhibrx, Inc.
| -26.00K |
$25.42 | -$660,841.96 | -1.03% | 2.49M |
Jan 23 - Jan 24
|
Scheduled
| ||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Inhibrx, Inc.
| -26.00K |
$25.56 | -$664,443.36 | -1.02% | 2.51M |
Dec 19
|
Scheduled
| ||||||
Inhibrx, Inc.
| -26.00K |
$27.88 | -$724,909.78 | -1.01% | 2.54M |
Nov 17
|
Scheduled
| ||||||
Inhibrx, Inc.
| -26.00K |
$29.59 | -$769,443.22 | -1.00% | 2.56M |
Oct 17
|
Scheduled
| ||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
| 3.09M |
Dec 28 - Jan 15
| |||||||
Inhibrx, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aeolus Pharmaceuticals, Inc.
| -3.99M |
$0.62 | -$2,464,479.64 | -47.86% | 4.35M |
Mar 15 - Mar 16
| |||||||
Aeolus Pharmaceuticals, Inc.
| -64.60K |
$0.97 | -$62,522.00 | -0.77% | 8.34M |
Feb 15 - Feb 16
| |||||||
Aeolus Pharmaceuticals, Inc.
| -1.39M |
—
|
—
| -14.22% | 8.41M |
Jan 6 - Feb 8
| |||||||
Repros Therapeutics Inc.
| -156.80K |
$0.67 | -$105,702.41 | -5.79% | 2.55M |
Dec 17 - Dec 21
| |||||||
Repros Therapeutics Inc.
| -386.10K |
$0.68 | -$264,235.10 | -12.47% | 2.71M |
Dec 11 - Dec 15
| |||||||
Repros Therapeutics Inc.
| -541.00K |
$0.70 | -$380,553.40 | -14.88% | 3.1M |
Nov 30 - Dec 2
| |||||||
Repros Therapeutics Inc.
| -656.00K |
$0.72 | -$471,400.40 | -15.28% | 3.64M |
Nov 19 - Nov 23
| |||||||
Repros Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 20
| |||||||
Repros Therapeutics Inc.
| 11.3K |
$7.76 | $87,688.00 | +0.26% | 4.29M |
Oct 31
| |||||||
Repros Therapeutics Inc.
| 11.3K |
$7.76 | $87,688.00 | +0.26% | 4.29M |
Oct 31
| |||||||
Repros Therapeutics Inc.
| 34.29K |
$6.94 | $238,026.04 | +0.81% | 4.28M |
Oct 28 - Oct 29
| |||||||
Repros Therapeutics Inc.
| 34.29K |
$6.94 | $238,026.04 | +0.81% | 4.28M |
Oct 28 - Oct 29
| |||||||
Repros Therapeutics Inc.
| 62.13K |
$6.72 | $417,644.13 | +1.48% | 4.25M |
Oct 23 - Oct 27
| |||||||
Repros Therapeutics Inc.
| 62.13K |
$6.72 | $417,644.13 | +1.48% | 4.25M |
Oct 23 - Oct 27
| |||||||
Repros Therapeutics Inc.
| 30K |
$6.42 | $192,600.00 | +0.72% | 4.18M |
Oct 17
| |||||||
Repros Therapeutics Inc.
| 30K |
$6.42 | $192,600.00 | +0.72% | 4.18M |
Oct 17
| |||||||
Repros Therapeutics Inc.
| 30.3K |
$6.52 | $197,619.00 | +0.73% | 4.15M |
Oct 10 - Oct 13
| |||||||
Repros Therapeutics Inc.
| 30.3K |
$6.52 | $197,619.00 | +0.73% | 4.15M |
Oct 10 - Oct 13
| |||||||
Repros Therapeutics Inc.
| 1.85M |
$6.50 | $12,000,001.00 | +81.04% | 4.12M |
Oct 2
| |||||||
Repros Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 29
| |||||||
Repros Therapeutics Inc.
| 1.85M |
$6.50 | $12,000,001.00 | +81.04% | 4.12M |
Oct 2
| |||||||
Repros Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 29
| |||||||
Repros Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Repros Therapeutics Inc.
| -302.06K |
$9.21 | -$2,783,355.78 | -11.71% | 2.28M |
Mar 14 - Mar 27
| |||||||
Repros Therapeutics Inc.
| 50K |
$8.50 | $425,000.00 | +1.98% | 2.58M |
Mar 12
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.